Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jul 24, 2026 (3 months ago)

Acamprosate Calcium (Acamprosate Calcium Enteric-Coated)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.

Affected NDC 0378-6333-80

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Acamprosate Calcium
acamprosate calcium enteric-coated
NDC 00378-6333
ACAMPROSATE CALCIUM 333 mg/1 Tablet, Delayed Release
Oral
Mylan Pharmaceuticals Inc. Rx
Recalling firm
Mylan Pharmaceuticals Inc
NDC code
0378-6333-80
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0774-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Mylan Pharmaceuticals Inc

All 2026 recalls
Class II · Moderate risk

Prasugrel Tablets

Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria

Ongoing Dissolution failure Mylan Pharmaceuticals Inc NDC 0378-5186-93 D-0839-2026

Other dissolution failure recalls from 2026

All dissolution failure recalls
Class III · Low risk

Trokendi XR

Failed dissolution specifications.

Ongoing Dissolution failure Supernus Pharmaceuticals, Inc. NDC 17772-102-30 D-0833-2026
Class II · Moderate risk

Prasugrel HCI

Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution

Ongoing Dissolution failure Golden State Medical Supply Inc. D-0847-2026